[Recommendations for initial diagnosis and therapy in acute blood coagulation disorders]. 1996

R Sütterlin, and D Barthels
Abteilung für Anästhesiologie und Intensivtherapie, Kreiskrankenhauses Bischofswerda, Dresden-Neustadt.

Acute disturbances of blood coagulation during operations and intensive therapy require quick and precise action in order to avoid life-threatening situations. This paper reports on a simple system for the diagnosis and therapy of acute disturbances of blood coagulation. In the initial phase of bleeding, determination of fibrin monomers, d-dimers, reptilase time, number of platelets and AT III enables diagnosis of disseminated intravascular coagulation (DIC), hyperfibrinolysis and consumption coagulopathy. Particular attention is paid to local hyperfibrinolysis, a relatively rare complication but of high diagnostic importance. After some remarks on the recommended clinical test parameters, the principles of the treatment of various coagulation disturbances are described. AT III is of special importance for the treatment of DIC, where as different opinions exist regarding the application of heparin. Aprotinin has long proved successful in the specific treatment of hyperfibrinolysis. Using clinical examples, the practicability of the recommended diagnostic and therapeutic measures is demonstrated.

UI MeSH Term Description Entries
D007431 Intraoperative Complications Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure. Peroperative Complications,Surgical Injuries,Complication, Intraoperative,Complication, Peroperative,Injuries, Surgical,Complications, Intraoperative,Complications, Peroperative,Injury, Surgical,Intraoperative Complication,Peroperative Complication,Surgical Injury
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females

Related Publications

R Sütterlin, and D Barthels
January 1976, Zentralblatt fur Gynakologie,
R Sütterlin, and D Barthels
September 1972, Medizinische Klinik,
R Sütterlin, and D Barthels
April 1968, Munchener medizinische Wochenschrift (1950),
R Sütterlin, and D Barthels
January 1980, Klinische Anasthesiologie und Intensivtherapie,
R Sütterlin, and D Barthels
January 1976, Acta medica Austriaca. Supplement,
R Sütterlin, and D Barthels
January 1957, Archiv fur Kinderheilkunde,
R Sütterlin, and D Barthels
February 1987, Fel'dsher i akusherka,
R Sütterlin, and D Barthels
February 1957, Gazette medicale de France,
R Sütterlin, and D Barthels
July 1994, Der Internist,
R Sütterlin, and D Barthels
February 1978, Die Medizinische Welt,
Copied contents to your clipboard!